BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 16170113)

  • 1. PET/CT imaging: detection of choroidal melanoma.
    Reddy S; Kurli M; Tena LB; Finger PT
    Br J Ophthalmol; 2005 Oct; 89(10):1265-9. PubMed ID: 16170113
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [(18)F]Fluorodeoxyglucose positron emission tomography/computed tomography (PET/CT) physiologic imaging of choroidal melanoma: before and after ophthalmic plaque radiation therapy.
    Finger PT; Chin KJ
    Int J Radiat Oncol Biol Phys; 2011 Jan; 79(1):137-42. PubMed ID: 20395070
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 18-Fluorine-labelled 2-deoxy-2-fluoro-D-glucose positron emission tomography/computed tomography standardised uptake values: a non-invasive biomarker for the risk of metastasis from choroidal melanoma.
    Finger PT; Chin K; Iacob CE
    Br J Ophthalmol; 2006 Oct; 90(10):1263-6. PubMed ID: 16837539
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The relationship between combined positron emission tomography/computed tomography and clinical and light microscopic findings in choroidal melanoma.
    Faia LJ; Pulido JS; Donaldson MJ; Salomão DR; Cameron JD; Mullan B; Gunduz K
    Retina; 2008 May; 28(5):763-9. PubMed ID: 18463523
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Whole body PET/CT for initial staging of choroidal melanoma.
    Finger PT; Kurli M; Reddy S; Tena LB; Pavlick AC
    Br J Ophthalmol; 2005 Oct; 89(10):1270-4. PubMed ID: 16170114
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association of positive dual-modality positron emission tomography/computed tomography imaging of primary choroidal melanoma with chromosome 3 loss and tumor size.
    McCannel TA; Reddy S; Burgess BL; Auerbach M
    Retina; 2010 Jan; 30(1):146-51. PubMed ID: 20010323
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Whole body positron emission tomography/computed tomography staging of metastatic choroidal melanoma.
    Kurli M; Reddy S; Tena LB; Pavlick AC; Finger PT
    Am J Ophthalmol; 2005 Aug; 140(2):193-9. PubMed ID: 15992753
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Initial PET/CT staging for choroidal melanoma: AJCC correlation and second nonocular primaries in 333 patients.
    Freton A; Chin KJ; Raut R; Tena LB; Kivelä T; Finger PT
    Eur J Ophthalmol; 2012; 22(2):236-43. PubMed ID: 21959680
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 18FDG-PET/CT assessing the absence of cell viability and excluding metastatic disease in a case of necrotic choroidal melanoma.
    Romero-Aroca P; Montero-Jaime M; Intriago B; Riu F; Peña-Gonzalez KB; Almena-Garcia M
    Eur J Ophthalmol; 2012; 22(2):288-92. PubMed ID: 21725939
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Second cancers discovered by (18)FDG PET/CT imaging for choroidal melanoma.
    Chin K; Finger PT; Kurli M; Tena LB; Reddy S
    Optometry; 2007 Aug; 78(8):396-401. PubMed ID: 17662928
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Radiation-related cancer risk associated with surveillance imaging for metastasis from choroidal melanoma.
    Wen JC; Sai V; Straatsma BR; McCannel TA
    JAMA Ophthalmol; 2013 Jan; 131(1):56-61. PubMed ID: 23307209
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinicopathological correlation for the role of fluorodeoxyglucose positron emission tomography computed tomography in detection of choroidal malignant melanoma.
    Matsuo T; Ogino Y; Ichimura K; Tanaka T; Kaji M
    Int J Clin Oncol; 2014 Apr; 19(2):230-9. PubMed ID: 23456141
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association of high metabolic activity measured by positron emission tomography imaging with poor prognosis of choroidal melanoma.
    Lee CS; Cho A; Lee KS; Lee SC
    Br J Ophthalmol; 2011 Nov; 95(11):1588-91. PubMed ID: 21317424
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Choroidal melanoma with hematogenous spread to the liver: F-18 FDG PET/CT findings.
    Bawa M; Sidhu G; Galt JR; Schuster DM; Halkar RK
    Clin Nucl Med; 2006 Jun; 31(6):347-8. PubMed ID: 16714898
    [No Abstract]   [Full Text] [Related]  

  • 15. Whole-body F-18-fluoro-2-deoxyglucose positron emission tomography/computed tomography imaging in the follow-up of metastatic uveal melanoma.
    Klingenstein A; Haug AR; Nentwich MM; Tiling R; Schaller UC
    Melanoma Res; 2010 Dec; 20(6):511-6. PubMed ID: 20890225
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Whole-body 18 FDG PET/CT imaging for lymph node and metastatic staging of conjunctival melanoma.
    Kurli M; Chin K; Finger PT
    Br J Ophthalmol; 2008 Apr; 92(4):479-82. PubMed ID: 18369064
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The sensitivity of computed tomography in the detection of malignant melanomas of the choroid].
    Müller-Miny H; Pötter R; Clemens S; Knocke TH
    Rofo; 1991 Apr; 154(4):425-9. PubMed ID: 1850160
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Metabolic activity of primary uveal melanoma on PET/CT scan and its relationship with monosomy 3 and other prognostic factors.
    Papastefanou VP; Islam S; Szyszko T; Grantham M; Sagoo MS; Cohen VM
    Br J Ophthalmol; 2014 Dec; 98(12):1659-65. PubMed ID: 25084771
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High-risk melanoma: accuracy of FDG PET/CT with added CT morphologic information for detection of metastases.
    Strobel K; Dummer R; Husarik DB; Pérez Lago M; Hany TF; Steinert HC
    Radiology; 2007 Aug; 244(2):566-74. PubMed ID: 17641374
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association Between Choroidal Thickness and Metabolic Activity on Positron Emission Tomography in Eyes With Choroidal Melanoma.
    Lee JH; Lee SC; Cho A; Keum KC; Suh YG; Lee CS
    Am J Ophthalmol; 2015 Dec; 160(6):1111-1115.e2. PubMed ID: 26343006
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.